VIVLION
LIVE

Serial Number

88024102

Owner

VIVLION GMBH

Attorney

Daniel A. Grossman

Filing Date

Jul 3, 2018

Add to watchlist:

No watchlists yet
View on USPTO

VIVLION Trademark

Serial Number: 88024102 • Registration: 5906320

VIVLION is a trademark filed by VIVLION GMBH on July 3, 2018. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

VIVLION GMBH (2 trademarks)

Moerfelder Landstr. 109A
FRANKFURT AM MAIN 60598 , DE

Entity Type: 16

Dr. Kerstin Koch

Mecklenburger Str. 7
Wiesbaden 65205 , DE

Entity Type: 01

Trademark Details

Filing Date

July 3, 2018

Registration Date

November 12, 2019

Published for Opposition

February 19, 2019

Goods & Services

Reagents for scientific use; chemical preparations for scientific and research purposes; biological preparations for scientific research purposes; biochemical products for scientific use in vivo and in vitro

Biological preparations for the treatment of cancer, neurodegeneration, immunologic diseases, cardiovascular diseases, metabolic diseases, infections, mental diseases and respiratory diseases for medical purposes; biochemical preparations for the treatment of cancer, neurodegeneration, immunologic diseases, cardiovascular diseases, metabolic diseases, infections, mental diseases and respiratory diseases for medical purposes; chemical reagents for medical purposes; biotechnological preparations for the treatment of cancer, neurodegeneration, immunologic diseases, cardiovascular diseases, metabolic diseases, infections, mental diseases and respiratory diseases for medical purposes; diagnostic agents, preparations and substances for medical purposes; diagnostic reagents for medical purposes; nucleic acid sequences for medical purposes; pharmaceutical preparations, therapeutic medicines and substances for the treatment of cancer, neurodegeneration, immunologic diseases, cardiovascular diseases, metabolic diseases, infections, mental diseases and respiratory diseases; nucleoside-containing pharmaceutical preparations, namely, antivirals for scientific biomedical purposes

Research and development services for the pharmaceutical industry; research and development services for the biotechnology sector; scientific research, testing and analysis services in the field of pharmaceuticals; laboratory research services in the field of pharmaceuticals; advisory services relating to technical and scientific analysis of pharmaceuticals; technical and scientific analysis in the field of pharmaceuticals; biomedical research; pharmaceutical research and development; scientific research for medical purposes; scientific research in the nature of analysis of large datasets relating to data connectivity, targeted data search; Provision of information and data relating to medical and veterinary research and development in the field of pharmaceuticals; Provision of information and data relating to scientific and technological research and development in the field of pharmaceuticals; computer aided scientific research analysis; Provision of online scientific information for industrial analysis and research in the field of pharmaceuticals; preparation of biological samples for scientific testing and analysis in research laboratories

Filing History

NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
Mar 11, 2026 NAS8
REGISTERED - SEC. 8 (6-YR) ACCEPTED
Mar 11, 2026 8.OK
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Mar 9, 2026 APRE
TEAS SECTION 8 RECEIVED
Oct 21, 2025 ES8R
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Nov 12, 2024 REM1
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Sep 20, 2024 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Sep 20, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Sep 20, 2024 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Sep 20, 2024 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Sep 20, 2024 COAR
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Sep 20, 2024 EWAF
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Sep 20, 2024 TCCA
TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
Sep 20, 2024 EWOR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Sep 20, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Sep 20, 2024 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Sep 20, 2024 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Sep 20, 2024 COAR
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Jan 29, 2020 ASGN
REGISTERED-PRINCIPAL REGISTER
Nov 12, 2019 R.PR
1(B) BASIS DELETED; PROCEED TO REGISTRATION
Oct 4, 2019 DP1B
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Oct 4, 2019 AITU
NOTICE OF ALLOWANCE CANCELLED
Aug 27, 2019 IUCN
TEAS DELETE 1(B) BASIS RECEIVED
Aug 27, 2019 D1BR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Aug 26, 2019 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Aug 26, 2019 REAP
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Apr 16, 2019 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 19, 2019 NPUB
PUBLISHED FOR OPPOSITION
Feb 19, 2019 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 30, 2019 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 15, 2019 CNSA
EXAMINER'S AMENDMENT ENTERED
Jan 15, 2019 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jan 15, 2019 GNEN
EXAMINERS AMENDMENT E-MAILED
Jan 15, 2019 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jan 15, 2019 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 12, 2018 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 12, 2018 CRFA
ASSIGNED TO LIE
Dec 12, 2018 ALIE
ASSIGNED TO EXAMINER
Dec 11, 2018 DOCK
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 10, 2018 TROA
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 21, 2018 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 21, 2018 CRFA
ASSIGNED TO LIE
Nov 21, 2018 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 9, 2018 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Oct 24, 2018 GNRN
NON-FINAL ACTION E-MAILED
Oct 24, 2018 GNRT
NON-FINAL ACTION WRITTEN
Oct 24, 2018 CNRT
ASSIGNED TO EXAMINER
Oct 24, 2018 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 9, 2018 NWOS
NEW APPLICATION ENTERED
Jul 6, 2018 NWAP